Osteopar Liquid
Product Images NDC 44911-0367

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Osteopar (NDC 44911-0367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Energique, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enrg0861 Osteopar 2 17 21

This is a warning label for a pain relief medication that may temporarily relieve pain in the lower back, sacroiliac area, joints, and bones. The label warns pregnant or breastfeeding individuals to consult a healthcare professional prior to use, and urges users to keep the medication out of reach of children. In the event of an overdose, medical help or contact with a Poison Control Center should be made immediately. It should not be used if the tamper-evident seal is broken or missing. The medication's traditional homeopathic practice-based claims are not verified by the FDA, with no accepted medical data supporting the claims. Users should seek advice from a health care professional if they experience symptoms for more than seven days, or for use in children under 12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.